BioNTech SE (BNTX) Inventory (2018 - 2025)
BioNTech SE (BNTX) posted Inventory of $128.9 million for Q4 2025, down 51.16% sequentially from $263.9 million in Q3 2025, and down 57.43% YoY from $302.7 million in Q4 2024.
BioNTech SE (BNTX) Inventory (2018 - 2025) Analysis & Trends
BioNTech SE has reported Inventory for 8 years, with the latest figure at $128.9 million in Q4 2025.
- Quarterly Inventory fell 57.43% year-over-year to $128.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $128.9 million (down 57.43% YoY) and the FY2025 annual result came in at $125.1 million, down 58.69% from the prior year.
- Inventory slipped to $128.9 million in Q4 2025 per BNTX's latest filing, from $263.9 million in the prior quarter.
- Over five years, Inventory peaked at $574.8 million in Q4 2021 and troughed at $128.9 million in Q4 2025.
- A 5-year average of $360.3 million and a median of $370.7 million in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2021 and 2025: Inventory soared 652.16% in 2021, then sank 57.43% in 2025.
- Over 5 years, Inventory stood at $574.8 million in 2021, then retreated by 21.98% to $448.5 million in 2022, then decreased by 14.19% to $384.9 million in 2023, then dropped by 21.34% to $302.7 million in 2024, then tumbled by 57.43% to $128.9 million in 2025.
- According to Business Quant data, Inventory over the past three periods registered $128.9 million, $263.9 million, and $261.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 128.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 128.86 Mn |
| Sep 30, 2025 | 263.86 Mn |
| Jun 30, 2025 | 261.14 Mn |
| Mar 31, 2025 | 267.60 Mn |
| Dec 31, 2024 | 302.73 Mn |
| Sep 30, 2024 | 332.87 Mn |
| Jun 30, 2024 | 366.25 Mn |
| Mar 31, 2024 | 375.23 Mn |
| Dec 31, 2023 | 384.86 Mn |
| Sep 30, 2023 | 452.53 Mn |
| Jun 30, 2023 | 488.82 Mn |
| Mar 31, 2023 | 455.20 Mn |
| Dec 31, 2022 | 448.50 Mn |
| Sep 30, 2022 | 297.24 Mn |
| Jun 30, 2022 | 392.36 Mn |
| Mar 31, 2022 | 515.49 Mn |
| Dec 31, 2021 | 574.85 Mn |
| Mar 31, 2021 | 177.20 Mn |
| Dec 31, 2020 | 76.43 Mn |
| Dec 31, 2019 | 12.97 Mn |